Guadalupe Bermudo

Suggest Changes
Learn More
BACKGROUND The 13-valent pneumococcal conjugate vaccine (PCV13) has recently been approved for use in immunocompromised adults. However, it is unclear whether there is an association between specific(More)
  • 1